Merck Appoints Heads For US And China
This article was originally published in Scrip
Merck (of Germany) has appointed Gary Zieziula president and managing director of the company's biopharma business in US and Canada and Marc Horn will lead the biopharma business in China as managing director. Zieziula joined Merck in 2014 as chief commercial officer in the US and has previously held senior level positions at Bristol Myers-Squibb, Roche and Amag Pharmaceuticals. Currently Horn is the regional chief financial officer (CFO) of Merck responsible for Eastern Asia for Healthcare, Life Science and Performance Materials. He has over 16 years' finance experience in the pharma and chemicals industry and has held positions at Bayer and Lanxess.
Register for our free email digests: